Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
The COVID-19 pandemic has highlighted the importance of vaccines in controlling the epidemic in sub-Saharan Africa and a renewed interest in vaccine research and development across the country.
Read Full NewsNeuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.
Researchers are testing CAR T-cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body’s defenses go rogue.
1.
Research identifies nearly 200 potential breast carcinogens in food packaging materials
2.
Asymptomatic or Minimally Symptomatic Myelofibrosis
3.
New drug combination shows particularly good results in patients with HPV-negative head and neck cancer
4.
Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma
5.
Glofitamab Regimen Improves Survival in DLBCL
1.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
2.
The Latest Causes and Symptoms of Bowen's Disease: All You Need to Know
3.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
4.
Understanding Dasatinib: A Promising Drug for Cancer Treatment
5.
The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
2.
Navigating the Complexities of Ph Negative ALL - Part XV
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
4.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
5.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge